Ninety-nine percent response rate in 586 radiation treatments for cutaneous T-cell lymphoma

Background: Cutaneous T-cell lymphoma (CTCL) is a skin tropic lymphoid neoplasm. Relapse is very common; particularly for advanced disease for which there is no cure despite an array of treatment modalities. Skin directed radiation therapy is effective for CTCL. This retrospective study was undertaken to assess response rates and toxicity in patients who received skin directed radiation therapy.